Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Dec 1;200(11):1335-1337.
doi: 10.1164/rccm.201908-1558ED.

Cystic Fibrosis Lung Disease and Immunometabolism. Targeting the NLRP3 Inflammasome

Affiliations
Editorial

Cystic Fibrosis Lung Disease and Immunometabolism. Targeting the NLRP3 Inflammasome

André M Cantin. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Neutrophil immunometabolism in cystic fibrosis. On exposure to LPS in the cystic fibrosis airway, the neutrophil increases its cytoplasmic levels of the M2 isoform of PKM2 (pyruvate kinase) and pro–IL-1β. Simultaneously, the NLRP3 inflammasome is activated through several mechanisms. PKM2 in association with PHD3 (prolyl hydroxylase-3) is stabilized and in conjunction with the coactivator P300 facilitates HIF1 (hypoxia inducible factor-1)–dependent transcription that further increases the synthesis of pro–IL-1β, PKM2, and HIF1, while reprogramming mitochondria to deviate glucose from the tricarboxylic acid cycle (TCA) to the glycolytic pathway. Increased glycolysis results in production of lactate, acidification of the cytoplasm, and accumulation of succinate, which helps stabilize the HIF1 complex. Mitochondria release reactive oxygen species (ROS) that further activate the NLRP3 inflammasome, which converts pro–IL-1β to active IL-1β through caspase-1–mediated cleavage. DAMP = damage-associated molecular patterns; NF-κB = nuclear factor-κB; PAMP = pathogen-associated molecular patterns; PPARγ = peroxisome proliferator-activated receptor-γ; TLR = toll-like receptors.

Comment on

References

    1. Stoltz DA, Meyerholz DK, Welsh MJ. Origins of cystic fibrosis lung disease. N Engl J Med. 2015;372:1574–1575. - PubMed
    1. Gentzsch M, Mall MA. Ion channel modulators in cystic fibrosis. Chest. 2018;154:383–393. - PMC - PubMed
    1. Cantin AM, Bilodeau G, Ouellet C, Liao J, Hanrahan JW. Oxidant stress suppresses CFTR expression. Am J Physiol Cell Physiol. 2006;290:C262–C270. - PubMed
    1. Le Gars M, Descamps D, Roussel D, Saussereau E, Guillot L, Ruffin M, et al. Neutrophil elastase degrades cystic fibrosis transmembrane conductance regulator via calpains and disables channel function in vitro and in vivo. Am J Respir Crit Care Med. 2013;187:170–179. - PubMed
    1. Corriveau S, Sykes J, Stephenson AL. Cystic fibrosis survival: the changing epidemiology. Curr Opin Pulm Med. 2018;24:574–578. - PubMed

Substances